Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing

Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, and...

Related Keywords

China ,United States ,Melissa Forst ,Dan Budwick ,Linkedin Xilio Therapeutics Inc ,Pacific Western Bank Pacwest ,Exchange Commission ,Xilio Therapeutics Inc ,Roche Group ,Genentech United States Inc ,Bain Capital Life Sciences ,Gilead Sciences Inc ,Nasdaq ,Xilio Therapeutics ,Rock Springs Capital ,License Agreement ,Gilead Sciences ,Pacific Western Bank ,Information Regarding ,Securities Act ,Regarding Forward Looking ,Private Securities Litigation Reform Act ,Quarterly Report ,Genentech United States ,Markets ,